SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $4,197,000 | -43.4% | 55,727 | +14.2% | 0.36% | -34.8% |
Q2 2019 | $7,418,000 | +23.7% | 48,819 | -3.0% | 0.55% | +28.2% |
Q1 2019 | $5,997,000 | +12.5% | 50,312 | +3.0% | 0.43% | -2.5% |
Q4 2018 | $5,333,000 | -54.2% | 48,870 | -32.1% | 0.44% | -29.5% |
Q3 2018 | $11,632,000 | -41.7% | 72,018 | -52.3% | 0.63% | -42.8% |
Q2 2018 | $19,942,000 | -17.3% | 150,872 | -53.6% | 1.10% | -22.1% |
Q1 2018 | $24,106,000 | -38.4% | 325,356 | -53.7% | 1.41% | -38.8% |
Q4 2017 | $39,139,000 | +20.4% | 703,424 | -1.8% | 2.30% | +12.5% |
Q3 2017 | $32,501,000 | +62.9% | 716,516 | +21.1% | 2.05% | +58.4% |
Q2 2017 | $19,952,000 | +19.8% | 591,869 | +5.2% | 1.29% | +26.8% |
Q1 2017 | $16,651,000 | +91.8% | 562,522 | +77.8% | 1.02% | +73.9% |
Q4 2016 | $8,681,000 | – | 316,463 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |